These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9475829)

  • 1. Acyclovir- and ganciclovir-induced neurotoxicity.
    Ernst ME; Franey RJ
    Ann Pharmacother; 1998 Jan; 32(1):111-3. PubMed ID: 9475829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are varicella zoster and herpes simplex sentinel lesions for cytomegalovirus in renal transplant recipients?
    Lippmann BJ; Brennan DC; Wong J; Lowell JA; Singer GG; Howard TK
    Lancet; 1995 Sep; 346(8979):914-5. PubMed ID: 7564715
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the mailing list: use of acyclovir in patients on hemodialysis].
    D'Amico M; Fraticelli M; Limido A
    G Ital Nefrol; 2005; 22(1):66-9. PubMed ID: 15786379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir neurotoxicity: clinical experience and review of the literature.
    Adair JC; Gold M; Bond RE
    South Med J; 1994 Dec; 87(12):1227-31. PubMed ID: 7973922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity associated with acyclovir in end stage renal failure.
    Kitching AR; Fagg D; Hay NM; Hatfield PJ; Macdonald A
    N Z Med J; 1997 May; 110(1043):167-9. PubMed ID: 9196501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antiviral drugs during the neonatal period.
    Whitley RJ
    Clin Perinatol; 2012 Mar; 39(1):69-81. PubMed ID: 22341538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairment.
    Brady M; Main J
    Clin Med (Lond); 2009 Dec; 9(6):630. PubMed ID: 20095318
    [No Abstract]   [Full Text] [Related]  

  • 9. A Case Report of Neurotoxicity After Prolonged Doses of Acyclovir in a Patient With Renal Dysfunction.
    Umoru GO; Shah PJ; Tariq F
    J Pharm Pract; 2020 Apr; 33(2):217-221. PubMed ID: 30669921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of herpesvirus infections].
    Moeland A; Bruun JN
    Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2751-3. PubMed ID: 1658973
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin rash and splinter hemorrhages from ganciclovir.
    Lorenzi S; D'Antuono A; Iorizzo M; Tosti A
    J Dermatolog Treat; 2003 Sep; 14(3):177-8. PubMed ID: 14522628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir studies leave clinicians confused.
    AIDS Alert; 1995 Nov; 10(11):139-41. PubMed ID: 11362926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital cytomegalovirus infection. The role of ganciclovir in newborns].
    Aujard Y
    Arch Pediatr; 2014 Feb; 21(2):121-4. PubMed ID: 24377874
    [No Abstract]   [Full Text] [Related]  

  • 16. Ganciclovir.
    Med Lett Drugs Ther; 1989 Aug; 31(799):79-80. PubMed ID: 2549352
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China.
    Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB
    Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of herpesvirus infections in HIV-infected individuals.
    Fletcher CV
    Ann Pharmacother; 1992; 26(7-8):955-62. PubMed ID: 1324033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotoxicity of antiviral agents].
    Kanemitsu K; Ikejima H; Shimada J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):568-70. PubMed ID: 10434723
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotoxicity related to valganciclovir in a child with impaired renal function: usefulness of therapeutic drug monitoring.
    Peyrière H; Jeziorsky E; Jalabert A; Cociglio M; Benketira A; Blayac JP; Hansel S; Margueritte G; Hillaire-Buys D
    Ann Pharmacother; 2006 Jan; 40(1):143-6. PubMed ID: 16368917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.